title: [Regional vasoactive and metabolic therapy of patients with severe cranio-cerebral traumas].
abstract: In patients with severe cranio-cerebral traumas an investigation was performed of the efficiency of using vasoactive therapy in complex treatment directed to earlier recovery of the microcirculatory blood flow and aerobic metabolism in ischemic parts of the brain.
authors.forename: V N
authors.initials: VN
authors.lastname: Lapshin
authors.forename: B N
authors.initials: BN
authors.lastname: Shakh
authors.forename: V M
authors.initials: VM
authors.lastname: Teplov
authors.forename: D B
authors.initials: DB
authors.lastname: Smirnov
mesh_terms: D000328:Adult; D000332:Aerobiosis / Q000187:drug effects*; D000527:Alprostadil / Q000008:administration & dosage*; D002545:Brain Ischemia / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy; D002560:Cerebrovascular Circulation / Q000187:drug effects; D003131:Combined Modality Therapy / Q000379:methods; D006259:Craniocerebral Trauma / Q000150:complications / Q000175:diagnosis / Q000378:metabolism / Q000503:physiopathology; D016903:Drug Monitoring; D015600:Glasgow Coma Scale; D006801:Humans; D017078:Laser-Doppler Flowmetry; D008297:Male; D008833:Microcirculation / Q000187:drug effects*; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000627:therapeutic use; D012138:Respiratory Therapy / Q000379:methods*; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage
chemical_list: D018696:Neuroprotective Agents; D014665:Vasodilator Agents; D000527:Alprostadil